Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00569998 | Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin | PHASE3 | COMPLETED | 208 | — | — | Aug 1, 2003 | Feb 1, 2004 | Jan 19, 2017 | 23 | Austria, Germany +3 |
| Name | Type | Description |
|---|---|---|
| NovoPen™ 4 | DEVICE | - |
| NovoPen® 3 | DEVICE | - |
Inclusion Criteria: * Type 1 or type 2 diabetes mellitus for at least 12 months * Adults at least 18 years * Children/adolescents between 9-18 years * HbA1c lesser than or equal to 11.0% Exclusion Criteria: * Known or suspected alcohol or drug abuse * Patients who are not able to read the user ma...